| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.004 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.005 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |